Skip to content

Drug interactions

Lithium + Pazopanib

Severity: Major

Lithium and Pazopanib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pazopanib is labeled for QT prolongation and torsades de pointes, and lithium may add to repolarization effects. This increases arrhythmia risk, particularly with electrolyte abnormalities or underlying cardiac disease.

What this interaction means in plain words

Lithium and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Lithium belongs to Central Nervous System; Pazopanib belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid if an alternative mood stabilizer is feasible. Otherwise monitor the ECG and electrolytes at baseline and periodically, and correct potassium and magnesium.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lithium and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lithium with Pazopanib?

MediHelp rates the interaction as major. Lithium and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Pazopanib is labeled for QT prolongation and torsades de pointes, and lithium may add to repolarization effects. This increases arrhythmia risk, particularly with electrolyte abnormalities or underlying cardiac disease.

How serious is the interaction between Lithium and Pazopanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if an alternative mood stabilizer is feasible. Otherwise monitor the ECG and electrolytes at baseline and periodically, and correct potassium and magnesium.

What other medicines interact with Lithium?

MediHelp also lists interactions of Lithium with, for example, Thioridazine, Vandetanib, Aceclofenac. The full list is on the Lithium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in